Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Clin Immunol. 2020 Apr 2;40(4):592–601. doi: 10.1007/s10875-020-00773-y

Figure 4. Patients with co-morbid conditions have different immune parameters in CVID and IgG2D.

Figure 4.

Immune parameters were compared between patients with or without indicated co-morbid conditions in CVID and IgG2D. Only the parameters which were different (P < 0.05) between the comparison groups are shown here.